RT Journal Article
SR Electronic
T1 Factors associated with secondhand smoke exposure among non-smoking employees in the workplace: A cross-sectional study in Qingdao, China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.28.22269994
DO 10.1101/2022.01.28.22269994
A1 Jia, Xiaocen
A1 Wang, Rui
A1 Qiu, Xiaofei
A1 Huang, Yiqing
A1 Wang, Yani
A1 Jia, Xiaorong
A1 Li, Shanpeng
A1 Wu, Yibo
A1 Qi, Fei
YR 2022
UL http://medrxiv.org/content/early/2022/01/29/2022.01.28.22269994.abstract
AB Objective The study was designed to describe secondhand smoke (SHS) exposure among non-smoking employees in the workplace and identify factors that related exposure in Qingdao.Methods The study subjects covered the key non-smoking places stipulated in the “Qingdao City Smoking Control Regulations”. Airborne nicotine concentration in the workplace and saliva cotinine concentration of employees were measured. Questionnaire included employees’ demographics factors, smoke-free measures in the workplace, the employer’s tobacco hazard knowledge and attitudes towards smoke-free policy.Results A total of 222 non-smoking employees and 46 employees were included in the study. The median concentrations of airborne nicotine and salivary cotinine were 0.389 μg/m3 and 0.575 ng/ml. Educational status, average number of smokers per day and exposure time of SHS in the workplace, whether to divide smoking and non-smoking areas were related to the airborne nicotine concentration significantly. Age, educational status, exposure time of SHS in the workplace, tobacco control training and publicity and whether the employers support the “Qingdao Tobacco Control Regulation” were related to the salivary cotinine concentration significantly.Conclusions Exposure to SHS is highly prevalent among non-smoking employees in the workplace. Interventions to reduce SHS exposure in the workplace are urgently needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe design, data collection and analysis, decision to publish, or preparation of this study was funded by Medical and Health Discipline Construction Project of Qingdao (2020B047)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Qingdao Municipal CDCI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.